Assignee
NERVIANO MEDICAL SCIENCES SRL
IT·63 granted patents·23 pending applications·196 citations·filing 2001–2024
Top patents by PatentIndex Score
86 records- 0194US9682083B2Pyrrolo[2,3-D]pyrimidine derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Jun 20, 2017·30 cites·7 claims
- 0294US9102662B2Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Aug 11, 2015·13 cites·30 claims
- 0394US7482354B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2004·Granted Jan 27, 2009·44 cites·13 claims
- 0493US9604980B2Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2013·Granted Mar 28, 2017·31 cites·10 claims
- 0591US9616059B2Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2015·Granted Apr 11, 2017·6 cites·13 claims
- 0690US11491158B2N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2021·Granted Nov 8, 2022·2 cites·5 claims
- 0790US10561660B2N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted Feb 18, 2020·5 cites·7 claims
- 0889US10918642B2N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2019·Granted Feb 16, 2021·3 cites·1 claims
- 0989US10081622B2Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted Sep 25, 2018·4 cites·5 claims
- 1088US2025011333A1Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2023·Application pending·0 cites
- 1187US9688661B2Substituted pyrroles active as kinases inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2013·Granted Jun 27, 2017·4 cites·5 claims
- 1287US9255087B2Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Feb 9, 2016·5 cites·15 claims
- 1386US9085558B2Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Jul 21, 2015·4 cites·29 claims
- 1486US9085565B2Process for the preparation of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamideNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Jul 21, 2015·4 cites·8 claims
- 1585US10800739B24-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2019·Granted Oct 13, 2020·1 cites·4 claims
- 1684US9382235B2Unsolvated crystalline form 1 of N-[5-(3, 5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide and methods of use thereofNERVIANO MEDICAL SCIENCES SRL·Filed 2015·Granted Jul 5, 2016·3 cites·11 claims
- 1784US7618982B2Heteroarylpyrrolopyridinones active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2005·Granted Nov 17, 2009·8 cites·9 claims
- 1883US8354399B2Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2009·Granted Jan 15, 2013·6 cites·14 claims
- 1982US9464090B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2015·Granted Oct 11, 2016·2 cites·10 claims
- 2079US11833153B2N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2022·Granted Dec 5, 2023·0 cites·3 claims
- 2179US11773064B24-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2022·Granted Oct 3, 2023·0 cites·6 claims
- 2279US10280176B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted May 7, 2019·1 cites·11 claims
- 2379US9527863B2Thieno-indole moieties and methods of treating using the sameNERVIANO MEDICAL SCIENCES SRL·Filed 2013·Granted Dec 27, 2016·4 cites·9 claims
- 2479US2022144813A1Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2021·Application pending·0 cites
- 2578US2024350501A1SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO) PIPERIDIN-1-YL]-2-METHOXYPHENYL}AMINO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-h]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION, AND FORMULATIONS CONTAINING ITNERVIANO MEDICAL SCIENCES SRL·Filed 2024·Application pending·0 cites
- 2677US10385018B24-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2013·Granted Aug 20, 2019·2 cites·4 claims
- 2777US9637497B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2016·Granted May 2, 2017·1 cites·4 claims
- 2877US9561290B2Functionalized thieno-indole derivatives for the treatment of cancerNERVIANO MEDICAL SCIENCES SRL·Filed 2013·Granted Feb 7, 2017·2 cites·6 claims
- 2977US9145418B2Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2012·Granted Sep 29, 2015·6 cites·13 claims
- 3077US9056854B2Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Jun 16, 2015·2 cites·7 claims
- 3175US2021300935A1Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2020·Application pending·0 cites
- 3273US2020377487A1Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2019·Application pending·0 cites
- 3372US10738037B2Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamideNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted Aug 11, 2020·1 cites·18 claims
- 3471US11420940B24-carboxamido-isoindolinone derivatives as selective parp-1 inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2020·Granted Aug 23, 2022·0 cites·1 claims
- 3570US2019241546A1Substituted indazole derivatives active as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2018·Application pending·0 cites
- 3669US7642229B2Pharmaceutical composition and a product which includes a substituted acryloyl distamycin derivative, an antimicrotubule agent and/or an antimetaboliteNERVIANO MEDICAL SCIENCES SRL·Filed 2001·Granted Jan 5, 2010·1 cites·9 claims
- 3769US2019194214A1Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2019·Application pending·0 cites
- 3868US2022016122A1SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO) PIPERIDIN-1-YL]-2-METHOXYPHENYL}AMINO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-h]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION, AND FORMULATIONS CONTAINING ITNERVIANO MEDICAL SCIENCES SRL·Filed 2021·Application pending·0 cites
- 3965US10479779B2Substituted pyrroles active as kinases inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2018·Granted Nov 19, 2019·0 cites·5 claims
- 4065US10479778B2Substituted pyrroles active as kinases inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted Nov 19, 2019·0 cites·16 claims
- 4165US10071986B2Substituted pyrroles active as kinases inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted Sep 11, 2018·0 cites·2 claims
- 4262US2025206724A1Substituted 3-amino indazole derivatives as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2023·Application pending·0 cites
- 4361US10478423B2Substituted indazole derivatives active as kinase inhibitiorsNERVIANO MEDICAL SCIENCES SRL·Filed 2018·Granted Nov 19, 2019·0 cites·14 claims
- 4461US9649306B2Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamideNERVIANO MEDICAL SCIENCES SRL·Filed 2016·Granted May 16, 2017·0 cites·10 claims
- 4561US2010022553A1Therapeutic Combination Comprising an Aurora Kinase Inhibitor and ImatinibNERVIANO MEDICAL SCIENCES SRL·Filed 2009·Application pending·0 cites
- 4661US2011129467A1Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agentsNERVIANO MEDICAL SCIENCES SRL·Filed 2009·Application pending·0 cites
- 4760US11091469B2Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamideNERVIANO MEDICAL SCIENCES SRL·Filed 2020·Granted Aug 17, 2021·0 cites·24 claims
- 4859US10556913B2Asymmetric process for the preparation of thieno-indoles derivativesNERVIANO MEDICAL SCIENCES SRL·Filed 2018·Granted Feb 11, 2020·0 cites·5 claims
- 4959US2011118278A1Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugsNERVIANO MEDICAL SCIENCES SRL·Filed 2009·Application pending·0 cites
- 5058US2011117212A1Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agentNERVIANO MEDICAL SCIENCES SRL·Filed 2009·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NERVIANO MEDICAL SCIENCES SRL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →